Price target

1,666.860.000.00%
The 7 analysts offering 1-year price forecasts have a max estimate of — and a min estimate of —.

Analyst rating

Based on 7 analysts giving stock ratings in the past 3 months.

Recent analyst actions

Additional analyst data from Benzinga.

Date
Company
Analyst
Action
Rating change
Price target change
Disclaimer

Frequently asked questions


PharmaEssentia Corp. is expected to report ‪8.49 B‬ TWD in revenue for the next quarter, based on analyst estimates.

How to read forecasts:
– Compare with previous periods: Identify growth or slowdown trends
– Watch estimate revisions: Changes may signal shifting sentiment
– Check segment expectations: Some business lines may drive growth more than others

What to use alongside:
– Earnings (EPS): Profitability alongside revenue
– Margins: Efficiency and cost control
– Market news: Management outlook and market context
Analysts set the 6446 price target at 1,666.86 TWD, with estimates ranging from 1,235.00 TWD (low) to 2,143.00 TWD (high).

How to read price targets:
– Compare with current price: Shows potential upside or downside
– Watch the spread: A wide range suggests higher uncertainty
– Track revisions: Upgrades/downgrades can signal shifting sentiment

What to use alongside:
– Technical analysis: Trends, support/resistance, momentum
– Fundamentals: Revenue, earnings, margins
– Market news: Events that may impact future price
PharmaEssentia Corp. is currently rated "Buy" based on the opinions of 7 analysts over the past 3 months.

How to read analyst ratings:
– Check distribution: Buy vs Hold vs Sell recommendations
– Compare with price targets: Understand expected upside/downside
– Account for diverse opinions: Not all analysts agree — breakdown matters

Go further with your analysis:
– Open the Fundamentals graphs to chart key financial metrics and analyze trends over time
– Use the Stock Screener to compare across the market and find similar opportunities
– Follow market news to understand what’s driving sentiment and price moves